# Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage

Study · id `cardio:ct-nct04657133` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04657133](<https://clinicaltrials.gov/study/NCT04657133>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04657133

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 452 participants.

## Technical summary

Registry record NCT04657133. Randomized; quadruple masking; primary purpose treatment. Start 2021-04-22 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 452 participants (planned count; ClinicalTrials.gov record NCT04657133, source copy `cardio:ctgov-nct04657133-2022-07-19`, retrieved 2026-10-26)
- Started: 2021-04-22 (actual) (ClinicalTrials.gov record NCT04657133, source copy `cardio:ctgov-nct04657133-2022-07-19`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT04657133, source copy `cardio:ctgov-nct04657133-2022-07-19`, retrieved 2026-10-26)
- Completion: 2023-06-30 (anticipated) (ClinicalTrials.gov record NCT04657133, source copy `cardio:ctgov-nct04657133-2022-07-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04657133, source copy `cardio:ctgov-nct04657133-2022-07-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04657133-2022-07-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage
- Acronym: RICH-2
- Condition: Intracerebral Hemorrhage
- Condition: Acute Stroke
- Intervention (Device): Remote ischemic conditioning
- Intervention (Device): Sham remote ischemic conditioning
- Intervention (Drug): Standard medication therapy
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Capital Medical University (`cardio:org-capital-medical-university`)

## Provenance

Content hash: b0786f4d52a1a28c4d36e54db9aab17bbf3e09707e895fd07e7558ab95f531a9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
